Muscle cramps can result from dehydration, mineral loss, or overuse during exercise. Kidney failure and diabetes may increase your likelihood of muscle cramps. Staying hydrated and stretching can help ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

This shoulder workout is all about controlled power and consistent volume. Kali Muscle and Big Boy go through an intense series of deltoid-focused exercises, demonstrating what true Alpha male ...

Research reveals a host of perks you should know about.

Given that the latest tariffs can also be legally challenged, they might just be a measure to buy some time for another tariff option: Section 301 of the 1974 law.

Kyverna is leading other companies in the CAR-T sector. Their flagship product is KYV-101. It takes cells from the patient and engineers them with CD28 stimulation. Kyverna’s KYSA-8 delivered data on ...

NINE years ago, Sivasangaran Kumaran and his wife Prema Latha were overjoyed to welcome their second child, Swathi Nisha Nair, who was delivered naturally. Nothing seemed unusual until six months ...

Stay ahead of the action with our up-to-date UFC fight schedule. Below, you'll find all of the upcoming Fight Night events and pay-per-view cards, along with confirmed matchups and the latest odds ...

The first UFC Fight Night of 2026 goes down on Saturday from the Meta APEX in Las Vegas. In the main event, Mario Bautista and Vinicius Oliveira will clash in a bantamweight fight. Bautista has been ...

O’Malley Blames Paramount deal for Strickland’s presser getting cut short Sean O'Malley believes the UFC, by itself, doesn’t want to restrict speech in any way.

Jai Opetaia has been the biggest signing for Zuffa Boxing, and now he has his first opponent set. Opetaia will face Brandon Glanton in the main event of Zuffa Boxing 04 on March 8 at the Meta APEX in ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...